Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1602, 2007-01, pp. : 2-2
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
US drug approvals driven by science or commerce?
Reactions Weekly, Vol. 1, Iss. 1167, 2007-01 ,pp. :
Access to resources
Recommend
Off-label drug promotion in the US out of control?
Inpharma, Vol. 1, Iss. 1650, 2008-01 ,pp. :
Where is drug spending headed in the US for 2008?
Inpharma, Vol. 1, Iss. 1630-1631, 2008-01 ,pp. :
US vs Europe: are claims of drug price differences justified?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 609, 2010-01 ,pp. :
The return of Tysabri to the market in the US?
Inpharma, Vol. 1, Iss. 1529, 2006-01 ,pp. :